Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn...
-
Upload
nash-godby -
Category
Documents
-
view
218 -
download
0
Transcript of Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn...
![Page 1: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/1.jpg)
Recreating in silico the Natural History of Antibiotic Resistance
Daniel BarkerRosanna Alderson John Mitchell
![Page 2: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/2.jpg)
β-lactamase superfamily
The metallo-β-lactamase
superfamily
β-lactam hydrolysis
Metallo-β-lactamase classification
![Page 3: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/3.jpg)
β-lactamase superfamily
β-lactam hydrolysis
Metallo-β-lactamase classification
• CATH code 3.60.15.10
• Very diverse in range of substrate type.
• Overall chemical mechanism for both - lactamases and glyoxalases is hydrolysis catalysed via a metal ion, commonly zinc, that activates a water molecule.
• Superfamily also includes the flavoproteins in which a beta-lactamase domain has joined onto a flavodoxin domain.
“-lactamase” superfamily: An homologous superfamily of evolutionarily related proteins of similar structure, but with functional diversity – not all are -lactamases .
![Page 4: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/4.jpg)
β-lactamase superfamily
β-lactam hydrolysis
Metallo-β-lactamase classification
β-lactam water substituted β-amino acid
ccMoxalactam Hydrolysis
(S. maltophilia L1)
Spencer, J. et al (2005): scheme 1
![Page 5: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/5.jpg)
β-lactamase superfamily
β-lactam hydrolysis
Metallo-β-lactamase classification
M0015 1znb (B1)
M0258 1sml (B3)
![Page 6: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/6.jpg)
β-lactamase superfamily
β-lactam hydrolysis
Metallo-β-lactamase classification
β- lactamases
B3
B1
![Page 7: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/7.jpg)
β-lactamase superfamily
β-lactam hydrolysis
Metallo-β-lactamase classification
subclass B1
subclass B2
subclass B3
Class A
Class B
Class C
Class D
β- lactamases
subclass B1
subclass B2
subclass B3
The subclasses B1/B2 and B3 should be considered as distinct as the major classes of lactamase e.g. the serine lactamases to reflect their relative diversity in sequence and structure.
![Page 8: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/8.jpg)
Were there two independent evolutionary origins of β-lactam hydrolysis in the metallo-β-
lactamase superfamily?
![Page 9: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/9.jpg)
What was the likely function of the common ancestor of the B1 & B3 subclasses?
…
Is it likely that lactam hydrolysis evolved independently more than once in this superfamily?
![Page 10: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/10.jpg)
A simplistic analogy …
![Page 11: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/11.jpg)
… what do these people have in common?
![Page 12: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/12.jpg)
… what do these people have in common?
![Page 13: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/13.jpg)
… what do these people have in common?
![Page 14: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/14.jpg)
… what do these people have in common?
![Page 15: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/15.jpg)
… what do these people have in common?
Andy SMITH Terry SMITH Anne SMITH
![Page 16: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/16.jpg)
Going back a number of generations, individuals will share common ancestors …
![Page 17: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/17.jpg)
Warning: the following diagram is purely illustrative. No real family trees were harmed in the making of this diagram.
![Page 18: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/18.jpg)
![Page 19: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/19.jpg)
![Page 20: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/20.jpg)
Was this common ancestor a Smith …
![Page 21: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/21.jpg)
… or did the trait “Smith” originate independently more than once in the same lineage?
![Page 22: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/22.jpg)
![Page 23: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/23.jpg)
MRCA not a Smith
“Smith” arises independently multiple times
![Page 24: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/24.jpg)
Previous Work
Building trees and the Most Recent Common Ancestor
(MRCA)approach
Unresolved consensus tree…Building trees MRCA approach
![Page 25: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/25.jpg)
Previous Work Unresolved consensus tree…Building trees MRCA approach
11
6
41
![Page 26: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/26.jpg)
Previous Work Unresolved consensus tree…Building trees MRCA approach
MAFFT- amino acid alignment
Estimate parameters for
tree building from data
Maximum Likelihood trees built in PhyML
(100 bootstrap replicates WAG+G+I)
Orthologous sequences chosen, double no. of each
functional class from UniProtKBdatabase
Profile aligned against
‘FunTree’alignment
low gap penalty
![Page 27: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/27.jpg)
Previous Work Unresolved consensus tree…Building trees MRCA approach
Flavoproteins B1 lactamasesB2 lactamases
B3 lactamases GlyoxalasesRibonucleases
?
We reconstruct the phylogeny 100 times using randomised bootstrap replicates
![Page 28: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/28.jpg)
Previous Work Unresolved consensus tree…Building trees MRCA approach
Flavoproteins B1 lactamasesB2 lactamases
B3 lactamases GlyoxalasesRibonucleases
?
If we got an unambiguous tree topology, we could study a single MRCA …
![Page 29: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/29.jpg)
Previous Work Unresolved consensus tree…Building trees MRCA approach
Flavoproteins B1 lactamasesB2 lactamases
B3 lactamases GlyoxalasesRibonucleases
?
… but the order of branching is not clearly resolved
![Page 30: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/30.jpg)
Previous Work Unresolved consensus tree…Building trees MRCA approach
>1 ----------------------iplp------plsdg--vy-yvwld---------------eftgfgag------------------pltgllv---ypdgri------li----d-----pvcgeggthgllnwg-apg-----klgr-------klkyilithghgdhigglwgllkir--ga-------tvygp------------ggtrallprg--g--------------------------eytlflkggwpdcyy---pga--------------------------------hycd---------rwivwlpeg-rvllg-----------------g---ccfgyrf---avp--gkl-----------------------------------------------------gd--ltlacd-------ftavlvhe-----------y---------------wpktiddyr--sk----fdqvaelg---gvkklipghgd-----------------------------------ggq-----g--lllkayr---dff------------------------------------------------------>2---------------------------------lldg--vy----------------------flgfslg-------------------ry-lwi--yyprgcv------lf----d-----pgcgegtphllkhigfapg-----vigr-------glkyillthghgdhvgglkelleif--ga-------tvygp------------agtaallarg--glmfpy-gl------------------eytlllgrgwpdfyy---plp---------------------------------gcd---------rlihpgpgdtrvflg-----------------d---clfgyhl---dpg--gtl-----------------------------------------------------gd--iclacdp--egirgpdvlcgd----------rc-------f-------wpktle--k--ds----fdkikelpkcdglkcllgghgg----------------------------------ygrq-----glkllirkyr---elf------------------------------------------------------>3 ---------------------------------------iy-yglld---------------gfagfgav-------------------lt-lwv---tpdgli------lf----d-----ggcgdgtphllldwg-vpg-----pigk-------klkyilithghgdhigglgllgcrr--ga-------yvygp------------gggrlllpkg--g--------------------------ddtlllgggwpdfyy---pga--------------------------------hwpd---------rvirwlpeg-rvllg-----------------g---cvftarl---tlg--gtl-----------------------------------------------------gc--ltwpckgldglkpgcdvlvge-----------y-------y-------ypgliddyr--hr----fpqaralp---gclillpghgg-----------------------------------ggq-----g--lllkeyl---ely------------------------------------------------------
ASR
So we went back to our 100 bootstrap reconstructed trees …
![Page 31: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/31.jpg)
Previous Work Unresolved consensus tree…Building trees MRCA approach
>1 ----------------------iplp------plsdg--vy-yvwld---------------eftgfgag------------------pltgllv---ypdgri------li----d-----pvcgeggthgllnwg-apg-----klgr-------klkyilithghgdhigglwgllkir--ga-------tvygp------------ggtrallprg--g--------------------------eytlflkggwpdcyy---pga--------------------------------hycd---------rwivwlpeg-rvllg-----------------g---ccfgyrf---avp--gkl-----------------------------------------------------gd--ltlacd-------ftavlvhe-----------y---------------wpktiddyr--sk----fdqvaelg---gvkklipghgd-----------------------------------ggq-----g--lllkayr---dff------------------------------------------------------>2---------------------------------lldg--vy----------------------flgfslg-------------------ry-lwi--yyprgcv------lf----d-----pgcgegtphllkhigfapg-----vigr-------glkyillthghgdhvgglkelleif--ga-------tvygp------------agtaallarg--glmfpy-gl------------------eytlllgrgwpdfyy---plp---------------------------------gcd---------rlihpgpgdtrvflg-----------------d---clfgyhl---dpg--gtl-----------------------------------------------------gd--iclacdp--egirgpdvlcgd----------rc-------f-------wpktle--k--ds----fdkikelpkcdglkcllgghgg----------------------------------ygrq-----glkllirkyr---elf------------------------------------------------------>3 ---------------------------------------iy-yglld---------------gfagfgav-------------------lt-lwv---tpdgli------lf----d-----ggcgdgtphllldwg-vpg-----pigk-------klkyilithghgdhigglgllgcrr--ga-------yvygp------------gggrlllpkg--g--------------------------ddtlllgggwpdfyy---pga--------------------------------hwpd---------rvirwlpeg-rvllg-----------------g---cvftarl---tlg--gtl-----------------------------------------------------gc--ltwpckgldglkpgcdvlvge-----------y-------y-------ypgliddyr--hr----fpqaralp---gclillpghgg-----------------------------------ggq-----g--lllkeyl---ely------------------------------------------------------
ASR
… and obtained the sequence of the putative MRCA of B1, B2 & B3 in each tree.
![Page 32: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/32.jpg)
Previous Work Unresolved consensus tree…Building trees MRCA approach
H S S S F F
{H, S}S
{S, F}
S
{S ,F}
We had reconstructed the sequence probabilistically for each node of the tree for each of our 100 runs. So we had 100 putative MRCA sequences.
![Page 33: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/33.jpg)
100 MRCAs
47 match IPR001018 53 do not match
47 of the 100 MRCA sequence predictions hit InterPro signature IPR001018, “Beta-lactamase, class-B, conserved site.”
Previous Work Unresolved consensus tree…Building trees MRCA approachMRCA approach
![Page 34: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/34.jpg)
100 MRCAs
47 match IPR001018 53 do not match
A match to IPR001018, “Beta-lactamase, class-B, conserved site,” indicates the presence of some key zinc binding and catalytic residues.
MRCA approachPrevious Work Unresolved consensus tree…Building trees
![Page 35: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/35.jpg)
100 MRCAs
47 match IPR001018 53 do not match
However, it should be considered necessary but not sufficient to indicate that the protein actually has the catalytic capability of hydrolysing -lactams.
MRCA approachPrevious Work Unresolved consensus tree…Building trees
![Page 36: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/36.jpg)
100 MRCAs
47 match IPR001018 53 do not match
So we need to find another way of looking for catalytic capability. We want to build 3D homology model structures of these putative ancestral proteins.
Previous Work Unresolved consensus tree…Building trees MRCA approach
![Page 37: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/37.jpg)
Previous Work Unresolved consensus tree…Building trees MRCA approach
47 match IPR001018-lactamase signature
2 21
11
11
11
3
6
13
3
7
2
Cluster at sequence ID of 60% 15 clusters.
![Page 38: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/38.jpg)
Previous Work Unresolved consensus tree…Building trees MRCA approach
1 11
11
11
11
1
1
1
1
1
1
Take 1 representative from each cluster …
47 match IPR001018-lactamase signature
![Page 39: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/39.jpg)
47 match IPR001018
1 11
11
11
11
1
1
1
1
1
1
… and build an homology model of it (I-Tasser).
Previous Work Unresolved consensus tree…Building trees MRCA approach
![Page 40: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/40.jpg)
15 cluster representative sequences
15 Homology models (I-Tasser).
Previous Work Unresolved consensus tree…Building trees MRCA approach
![Page 41: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/41.jpg)
Remember that matching sequence signature IPR001018 is considered necessary but not sufficient to indicate that the protein can hydrolyse -lactams.
We design a 3D template model, a match to which would provide stronger evidence of -lactamase activity. We built separate templates for B1, B2 and B3.
So we look for matches to those templates in the 15 homology models …
Previous Work Unresolved consensus tree…Building trees MRCA approach
![Page 42: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/42.jpg)
… and we find that one MRCA homology model hits our B3 template, but that there are no other matches.
Previous Work Unresolved consensus tree…Building trees MRCA approach
![Page 43: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/43.jpg)
47 match IPR001018-lactamase signature
2 21
11
11
11
3
6
13
3
7
2
The homology modelled MRCA that hits our B3 template is from a singleton cluster and hence represents only 1 of the 100 independent runs.
Previous Work Unresolved consensus tree…Building trees MRCA approach
![Page 44: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/44.jpg)
Discussion
How do we understand and interpret these results?
Previous Work Unresolved consensus tree…Building trees MRCA approach
![Page 45: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/45.jpg)
Interpretation 1 (Occam’s Razor)
We have found a feasible evolutionary trajectory in structure and sequence space that allows both B1/B2 and B3 metallo--lactamases to evolve from a common ancestor with -lactamase activity.
Since originating the same catalytic functionality twice in the same superfamily seems complex and difficult, we should prefer the simpler, more parsimonious, explanation.
This interpretation implies a single evolutionary origin of -lactamase activity in this superfamily.
![Page 46: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/46.jpg)
Interpretation 2 (statistical)
Only 1 out of 100 of our simulated reconstructed MRCAs corresponds to a protein with (presumptive) metallo--lactamase activity. So in 99% of cases we recreate an MRCA that is not a -lactamase.
The scenario where the MRCA is not a -lactamase is supported by a 99:1 majority of trials.
This interpretation implies two separate evolutionary origins in the same superfamily.
![Page 47: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/47.jpg)
In Support of Interpretation 1
We would need to convince ourselves that we are happy despite finding the catalytically competent ancestor in only 1 of 100 trials. Excuses might be …
• Our models don’t reproduce the selective pressure that real evolution operates under and hence driving force for the in silico ancestral sequences for be functional fitness-enhancing proteins is lacking;
• Ancient enzymes may have had a useful level of -lactamase activity without hitting the ‘modern’ 3D template. So we might have missed the functional active site of an ancestor because it doesn’t look like what we were expecting for a -lactamase.
![Page 48: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/48.jpg)
In Support of Interpretation 2
Beyond the 99:1 statistical argument …
• There are indeed several reported cases of the same function evolving twice in a given superfamily.
• Previous work by Hall et al. supported two separate origins, B1 & B2 gaining -lactamase function 1 billion years ago, and B3 acquiring it 2 billion years ago.
![Page 49: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/49.jpg)
Sitting on the fence: We don’t want to graft a simplistic interpretation onto the study. Supporters of either theory could find encouragement from our results.
![Page 50: Recreating in silico the Natural History of Antibiotic Resistance Daniel Barker Rosanna AldersonJohn Mitchell.](https://reader035.fdocument.pub/reader035/viewer/2022062409/56649c7c5503460f949315f1/html5/thumbnails/50.jpg)
Mitchell group – BSRC & EaStCHEM School of ChemistryPurdie Building rooms 150 &152
Ava Sih-Yu Chen Rosanna Alderson
Neetika Nath James McDonagh Luna De Ferrari
Rachael SkynerJohn Mitchell